Gene · 6599
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Baf155 regulates skeletal muscle metabolism via HIF-1a signaling. | PLoS Biol | 2023 | 37478146 | PubTator, text mining | PubMed |
| Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway. | Mol Biol Rep | 2023 | 37477799 | PubTator, text mining | PubMed |
| Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications. | Front Oncol | 2023 | 37476370 | PubTator, text mining | PubMed |
| Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors. | J Am Soc Mass Spectrom | 2023 | 37463068 | PubTator, text mining | PubMed |
| Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis. | Front Oncol | 2023 | 37456262 | PubTator, text mining | PubMed |
| SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy. | Int J Mol Sci | 2023 | 37446319 | PubTator, text mining | PubMed |
| Tissue-Specific Regulation of CFTR Gene Expression. | Int J Mol Sci | 2023 | 37445855 | PubTator, text mining | PubMed |
| An organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fate. | Sci Adv | 2023 | 37436979 | PubTator, text mining | PubMed |
| The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target. | Oncogene | 2023 | 37433987 | PubTator, text mining | PubMed |
| In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice. | Blood Adv | 2023 | 37428871 | PubTator, text mining | PubMed |
| FOXA2 controls the anti-oxidant response in FH-deficient cells. | Cell Rep | 2023 | 37405921 | PubTator, text mining | PubMed |
| Systems crosstalk between antiviral response and cancerous pathways via extracellular vesicles in HIV-1-associated colorectal cancer. | Comput Struct Biotechnol J | 2023 | 37389186 | PubTator, text mining | PubMed |
| p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells. | Int J Mol Sci | 2023 | 37372954 | PubTator, text mining | PubMed |
| Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy. | Biomolecules | 2023 | 37371564 | PubTator, text mining | PubMed |
| Carm1-arginine methylation of the transcription factor C/EBPα regulates transdifferentiation velocity. | Elife | 2023 | 37365888 | PubTator, text mining | PubMed |
| LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder. | Cell Oncol (Dordr) | 2023 | 37355516 | PubTator, text mining | PubMed |
Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling. | Theranostics | 2023 | 37351165 | PubTator, text mining | PubMed |
| Paralog-based synthetic lethality: rationales and applications. | Front Oncol | 2023 | 37350942 | PubTator, text mining | PubMed |
| FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. | Aging (Albany NY) | 2023 | 37348029 | PubTator, text mining | PubMed |
| Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity. | Cancers (Basel) | 2023 | 37345142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6599/papers?page=6